About Unichem Labs
Unichem Labs is a company based in Mumbai (India) founded in 1944. The company has 3,330 employees as of March 31, 2024. Unichem Labs offers products and services including Formulations and Active Pharmaceutical Ingredients.
- Headquarter Mumbai, India
- Employees 3330 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Unichem Laboratories Limited
-
Annual Revenue
$243.58 M (USD)19.07as on Mar 31, 2025
-
Net Profit
$16.15 M (USD)0as on Mar 31, 2025
-
EBITDA
$27.39 M (USD)0as on Mar 31, 2025
-
Latest Funding Round
$126.03 M (USD), Post-IPO
Apr 24, 2023
- Investors
-
Employee Count
3330
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Unichem Labs
Unichem Labs is a publicly listed company on the NSE with ticker symbol UNICHEMLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Unichem Labs
Unichem Labs offers a comprehensive portfolio of products and services, including Formulations and Active Pharmaceutical Ingredients.
Formulations are manufactured by Unichem Laboratories for various markets, contributing to health solutions.
Active Pharmaceutical Ingredients are produced by Unichem Laboratories for integration into drug formulations, enhancing quality and sustainability.
People of Unichem Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Unichem Labs
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $126.0M
-
First Round
First Round
(24 Apr 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Post-IPO - Unichem Labs | Valuation |
investors |
Investors in Unichem Labs
Unichem Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ipca Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and drug formulations are manufactured for therapeutic segments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Unichem Labs
Financial Statements - Unichem Labs
Unichem Labs Comparisons
Competitors of Unichem Labs
Frequently Asked Questions about Unichem Labs
Unichem Labs was founded in 1944 and raised its 1st funding round 79 years after it was founded.
Unichem Labs is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Prakash A Mody is the current CEO of Unichem Labs.
As of Mar 31, 2024, the latest employee count at Unichem Labs is 3,330.
Annual revenue of Unichem Labs is $243.58M as on Mar 31, 2025.
Unichem Labs was founded in 1944 in Mumbai, India, within the pharmaceutical sector. Active pharmaceutical ingredients and formulations are produced, with emphasis placed on gastroenterology, cardiology, diabetology, psychiatry, neurology, antibacterials, anti-infectives, and pain management. A biotech facility has been established for the development and commercialization of biosimilar products through recombinant DNA technologies. Operations are centered in India, serving global markets.
Unichem Labs offers Formulations and Active Pharmaceutical Ingredients.
Yes, Unichem Labs is publicly traded on NSE under the ticker symbol UNICHEMLAB.
Unichem Labs has 1 investor. Key investors include Ipca Laboratories.
The ticker symbol of Unichem Labs is UNICHEMLAB on NSE.